Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)
Clinical trial NCT01462578 · COMPLETED
Trial details
- NCT number
- NCT01462578
- Sponsor
- Technische Universität Dresden
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2018-08-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.